Sure is a good thing that all C-suite executives always have the best interests of shareholders at heart. If you want to read about a shocking abuse of power (allegedly) to steal control of a company from shareholders (allegedly), read this.
The article is NOT well written so you have to read the whole thing to understand the magnitude of the breathtakingly blatant actions (ALLEGEDLY !) but here’s an excerpt
Nymox is alleging that AscellaHealth—which Nymox refers to as “a would-be ‘black knight’ competitor”—resorted to “illegal and unlawful corporate espionage” because it couldn’t gain enough support from Nymox shareholders by “legitimate means.”
Nymox is accusing Ascella of using its ties to the ex-Nymox leaders to pass off an investment proposal as a way to learn confidential company information and take control of the company's assets via a kick-back scheme, according to the biotech’s Nov. 9 release.
The biotech claims that Ascella continues to “relentlessly” interfere with Nymox’s relationship with its shareholders, including publishing confidential Nymox information using the “Committee to Restore Nymox Shareholder Value,” in attempts to reap the benefits of Nymox’s pipeline, including Nymozarfex.
“Nymox is confident that it will be vindicated in court,” the company wrote in the Nov. 9 release.